000			01426na a2200385 4500
999			_c525 _d525
003			PC525
005			20210614111341.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aMérida Herrero, Evangelina _92030 _eNefrología
100			_aPraga Terente, Manuel _91488 _eNefrología
245	0	0	_aMycophenolate as Maintenance Therapy for Lupus Nephritis with Impaired Renal Function _h[artículo]
260			_bAmerican Journal of Nephrology, _c2013
300			_a 37(6):509-17.
500			_aFormato Vancouver: Rivera F, Illescas ML, López-Rubio E, Fulladosa J, Poveda R, Baltar J et al. Mycophenolate as maintenance therapy for lupus nephritis with impaired renal function. Am J Nephrol. 2013;37(6):509-17.
501			_aPMID: 23689615
504			_aContiene 33 referencias
520			_aBackground: Mycophenolate (MF) is effective as a maintenance therapy after induction therapy in patients with lupus nephritis (LN). However, little is known about its role in patients with impaired renal function. The purpose of this study was to evaluate the efficacy and safety of ME as a maintenance therapy for LN and its association with renal function. Methods: Data were obtained for 56 Spanish patients who were receiving
710			_986 _aServicio de Nefrología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc525.pdf _ySolicitar documento
942			_n0 _2ddc _cART